Novel oncogenic PTPN11 mutations in myelodysplastic syndrome in Korean patients

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 166-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

By  

Current Cancer Drug Targets, Vol. 6, Iss. 6, 2006-09 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Azacitidine beneficial in myelodysplastic syndrome

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Antiangiogenesis in Myelodysplastic Syndrome

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-01 ,pp. : 1044-1052

Bentham Science Publishers

Access to resources Recommend Favorite

Venous Thromboembolism in Myelodysplastic Syndrome Patients Receiving Lenalidomide: Results from Postmarketing Surveillance and Data Mining Techniques

By Yang Xionghu  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 161-171

Adis International

Access to resources Recommend Favorite